These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17185788)

  • 41. Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.
    Schuring AN; Schulte N; Sonntag B; Kiesel L
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):9-15. PubMed ID: 18209494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of polycystic ovary syndrome with an interstitial deletion of the long arm of chromosome 11.
    Meyer MF; Gerresheim F; Pfeiffer A; Epplen JT; Schatz H
    Exp Clin Endocrinol Diabetes; 2000; 108(8):519-23. PubMed ID: 11149629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].
    Chen ZJ; Shi YH; Zhao YR; Li Y; Tang R; Zhao LX; Chang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):582-5. PubMed ID: 15498182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [(TTTTA), polymorphism in the promoter of the CYP11A1 gene in the pathogenesis of polycystic ovary syndrome].
    Prazáková S; Vanková M; Bradnová O; Lukásová P; Vcelák J; Dvoráková K; Vondra K; Vrbíková J; Bendlová B
    Cas Lek Cesk; 2010; 149(11):520-5. PubMed ID: 21391350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The association between polymorphism of INSR and polycystic ovary syndrome: a meta-analysis.
    Feng C; Lv PP; Yu TT; Jin M; Shen JM; Wang X; Zhou F; Jiang SW
    Int J Mol Sci; 2015 Jan; 16(2):2403-25. PubMed ID: 25622255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
    Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
    Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of TLR2 S450S and ICAM1 K469E polymorphisms with polycystic ovary syndrome (PCOS) and obesity.
    Ojeda-Ojeda M; Martínez-García MÁ; Alpañés M; Luque-Ramírez M; Escobar-Morreale HF
    J Reprod Immunol; 2016 Feb; 113():9-15. PubMed ID: 26498675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
    Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
    Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.
    Martínez-García MA; San-Millán JL; Escobar-Morreale HF
    Gene; 2012 Apr; 497(1):38-44. PubMed ID: 22306327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA.
    Ilie IR; Georgescu CE
    Adv Clin Chem; 2015; 71():25-45. PubMed ID: 26411410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Correlation between interleukin-1 and the obesity of polycystic ovary syndrome].
    Yang Y; Qiao J; Li MZ
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):9-13. PubMed ID: 22455686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of follistatin and cytochrome p450 side-chain cleavage enzyme with polycystic ovarian syndrome.
    Nazir F; Inayatullah S; Jalali S
    Int J Health Sci (Qassim); 2022; 16(5):32-39. PubMed ID: 36101845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational analysis of the follistatin-related gene in women with premature ovarian failure and polycystic ovary syndrome.
    Kimura F; Takebayashi K; Fujiwara M; Akiyama M; Takahashi K; Noda Y
    Acta Obstet Gynecol Scand; 2006; 85(7):885-6. PubMed ID: 16817091
    [No Abstract]   [Full Text] [Related]  

  • 55. Current developments in the molecular genetics of the polycystic ovary syndrome.
    Franks S; Gharani N; Waterworth D; Batty S; White D; Williamson R; McCarthy M
    Trends Endocrinol Metab; 1998 Feb; 9(2):51-4. PubMed ID: 18406240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.
    Goodarzi MO; Dumesic DA; Chazenbalk G; Azziz R
    Nat Rev Endocrinol; 2011 Apr; 7(4):219-31. PubMed ID: 21263450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The genetics of the polycystic ovary syndrome.
    Urbanek M
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):103-11. PubMed ID: 17237837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
    Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
    Fertil Steril; 2009 Feb; 91(2):456-88. PubMed ID: 18950759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
    Rosenfield RL; Ehrmann DA
    Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypes and enviromental factors: their influence in PCOS.
    Diamanti-Kandarakis E; Christakou C; Marinakis E
    Curr Pharm Des; 2012; 18(3):270-82. PubMed ID: 22229564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.